ADRIANNA MARCUS: Open Payments
NPI 1720620362 · YUBA CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 57 payments from 12 companies in 2025. Trend: 2023 $593 · 2024 $2,238 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Verrica Pharmaceuticals Inc. | 32 | $278 |
| Janssen Biotech, Inc. | 6 | $113 |
| GENZYME CORPORATION | 4 | $98 |
| ABBVIE INC. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Incyte Corporation | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| UCB, Inc. | 1 | $32 |
| Galderma Laboratories, L.P. | 1 | $30 |
| Botanix SB Inc | 1 | $26 |
Products named: YCANTH, DUPIXENT, TREMFYA, OPZELURA, SKYRIZI, COSENTYX, Bimzelx, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
